1. Home
  2. QQQX vs PRCT Comparison

QQQX vs PRCT Comparison

Compare QQQX & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest

QQQX

Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest

HOLD

Current Price

$26.93

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$24.95

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QQQX
PRCT
Founded
2007
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
QQQX
PRCT
Price
$26.93
$24.95
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$35.44
AVG Volume (30 Days)
141.5K
2.0M
Earning Date
01-01-0001
04-23-2026
Dividend Yield
7.03%
N/A
EPS Growth
N/A
1.71
EPS
N/A
N/A
Revenue
N/A
$308,054,000.00
Revenue This Year
N/A
$31.62
Revenue Next Year
N/A
$24.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
37.22
52 Week Low
$20.35
$19.35
52 Week High
$28.81
$64.89

Technical Indicators

Market Signals
Indicator
QQQX
PRCT
Relative Strength Index (RSI) 39.62 43.03
Support Level $26.27 $19.35
Resistance Level $27.60 $29.06
Average True Range (ATR) 0.40 1.57
MACD -0.09 0.02
Stochastic Oscillator 16.67 35.70

Price Performance

Historical Comparison
QQQX
PRCT

About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest

Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the S&P 500 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets (as defined below) in a diversified equity portfolio made up of securities comprising the S&P 500 Index (or securities that have economic characteristics that are similar to those securities comprising the S&P 500 Index) that seeks to substantially replicate price movements of the S&P 500 Index and is designed to support the Fund's option strategy.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: